GSTM1 and cancer: Of 1106 patients referred on an urgent 2-week suspected cancer pathway with accompanying FIT, a f-Hb threshold of > 4 μg/g gave a sensitivity and specificity for colorectal cancer of 97.5% and 64.5% respectively.